Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034063 (
pulmonary edema
)
10,665
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mendelson's syndrome is discussed with a review of the literature and presentation of 27 personal cases studies. Accidental aspiration of gastric fluid occurs primarily during anesthesia, in cranial trauma victims, and in toxic coma patients. Tissue damage is proportional to the
acidity
and the quantity of aspirated fluid. The initial clinical manifestations are often serious, sometimes leading to acute respiratory distress syndrom with
pulmonary edema
. Frequent infectious complications, often with anaerobic microbes, are deciding factors in the prognosis. Artificial ventilation with positive pressure (sometimes continuous) is often necessary. Administration of corticosteroids at high doses is likely favorable. Prophylactic administration of antibiotics is initially directed against anaerobic agents. The prevention of this serious syndrome should be a primary concern of anesthesiologists and physicians treating comatous patients.
...
PMID:[Mendelson's syndrome]. 2 27
Dibutylhexamethylenediamine (DBHMD), a polymer intermediate, is strongly alkaline and is corrosive to eyes and skin. Its inhalation toxicity was defined in rats in both acute and subchronic studies. A 4-hr LC50 of 0.22 mg/litre was obtained for DBHMD of either 80.6 or 98.25% purity. Clinical signs of irritation were apparent during and immediately following exposure and no delayed deaths occurred. The mortality dose-response line was relatively steep. Reduction of exposure times to 5 min produced an LC50 of 51 mg/litre, with similar clinical signs and a steep dose-response line. These data suggest that the product of concentration and time (Ct) is constant for exposure times ranging from 5 min to 4 hr. Repeated (ten) exposures to 0.0125 mg/litre caused no signs of adverse response in rats. A concentration of 0.0234 mg/litre caused some mortality, mucous-membrane irritation, changes in haematological parameters (including erythrocyte counts, haemoglobin, concentration and total and differential leucocyte counts) and an increased
acidity
and decreased volume of urine. Death at this exposure level was attributed to cardiac failure secondary to
pulmonary oedema
and congestion, with evidence of hepatic congestion, diffuse cardiac myocytolysis and oedema, and thymic atrophy and congestion. Changes in the heart and thymus were seen in one of two rats killed after the tenth exposure. Clinical and pathological changes observed after the ten exposures were absent after a 14-day recovery period. DBHMD is highly toxic following acute inhalation and produces a steep dose-response following either single or multiple exposures.
...
PMID:Inhalation toxicity of dibutylhexamethylenediamine in rats. 653 32